Objective: Migration of smooth muscle cells (SMCs) from the media to the intima of arteries is involved in intimal thickening. The plateletderived growth factor (PDGF) BB is recognized as a major migratory factor for arterial SMCs both in vitro and during neointima formation. Since PDGF acts in synergy with the matrix protein osteopontin (OPN) and also induces its expression, the present study was conceived to explore the role of the OPN produced in an autocrine fashion by PDGF-stimulated SMCs in the migration process and to define regulatory mechanisms of OPN expression. Methods and results: PDGF stimulation of quiescent rat aortic SMCs induced their migration (transfilter assays) and the increase of OPN expression (mRNA and protein assays). Blockade of either OPN expression by a specific short interference RNA (siRNA) or of its function by a blocking antibody decreased the PDGF-stimulated migration by about 70%, demonstrating that autocrine production and excretion of OPN are integral to the PDGF-induced SMC migration. In parallel, SMC stimulation by PDGF also activated the transcription factor CREB essentially through mitogen-activated protein kinase (MAPK) 1/2 and protein kinase A (PKA) pathways. Inhibition of either CREB expression (via siRNA) or function (via dominant-negative CREB) decreased both PDGF-induced SMC migration and OPN expression. SMC transfection with OPN promoter reporter constructs demonstrated that PDGF-induced OPN transcription is mediated by CREB binding to two functional sites of the OPN promoter: a CRE site located at −1403 and an AP-1 site located at − 76. Conclusion: The present study demonstrates that the autocrine expression of OPN plays a major role in PDGF-induced SMC migration. It further shows that the transcription factor CREB, activated in PDGF-stimulated SMCs, plays a key role in PDGF-induced SMC migration, probably by regulating OPN expression.
Introduction
Since the seminal work of R. Ross and co-workers [1] , platelet-derived growth factor (PDGF) is recognized as one of the major factors involved in vascular remodelling and intimal lesion formation [2] . One remarkable property of PDGF is to be a potent inducer of arterial smooth muscle cell (SMC) migration and proliferation [2] . In vivo, the blockade of PDGF or of its receptors leads to reduction of myointimal hyperplasia Cardiovascular Research 75 (2007) 738 -747 www.elsevier.com/locate/cardiores in response to injury in animal models [3, 4] . In vitro experiments have demonstrated that the PDGF isoform BB is a better stimulant of SMC migration than the AB isoform, while the AA isoform is inactive [5] , or even inhibitory [6] . Moreover, studies using animal injury models showed that infusion of PDGF-BB promoted intimal thickening and promoted SMC migration from the media to intima [7] . Despite demonstrations of the crucial role played by PDGF in SMC migration, mechanisms involved in PDGFmediated SMC migration have not been fully defined. However, several studies report that integrin receptors, namely the vitronectin receptors αvβ3 and αvβ5, are involved in PDGF-induced SMC migration. Indeed, both integrin antibodies and RGD antagonist peptides, significantly inhibit PDGF-induced migration of SMCs [8] [9] [10] . These integrins are also receptors for osteopontin (OPN), a secreted phosphorylated glycoprotein, whose expression is induced by PDGF in arterial SMCs [11] . Moreover, OPN is a chemo-attractant for SMCs [12, 13] and its action is mediated particularly by the β3 integrin [10] . Furthermore, the autocrine OPN expression plays a central role in nucleotide-induced SMC migration [14] . In addition, the stimulation of SMCs with PDGF-BB and OPN together has been shown to increase the SMC production of matrix metalloproteinase-9 (MMP-9) [15] , suggesting that OPN might be involved via this mechanism in PDGF-induced migration.
Some of the various intracellular pathways activated by PDGF-BB in SMCs have been associated with the migration process, particularly the phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) 1/2 pathways [16, 17] . PDGF-mediated SMC activation also leads to gene induction, which is mediated by the activation of various transcription factors. Among them, the cAMPresponse element binding protein (CREB) is not only activated by PDGF-BB [18] , but also by other SMC chemotactic factors such as angiotensin 2 [19] , thrombin [20] , tumor necrosis factor-α (TNFα) [21] and extracellular nucleotides [22] , suggesting that this transcription factor might be involved in the regulation of SMC migration induced by these factors, an hypothesis verified for TNFα [21] .
In this study, our first aim was to determine whether the SMC-chemotactic protein OPN produced after SMC stimulation by PDGF was involved in SMC migration induced by this factor. Our second aim was to determine whether the transcription factor CREB, which is activated in SMC by several chemotactic factors, controlled mechanisms involved in PDGF-induced SMC migration and PDGF-activated OPN expression as well.
Materials and methods

Plasmids
Luciferase-reporter plasmids containing fragments of various lengths of the 5′region of the rat OPN promoter (− 1599luc, − 1014luc and − 294luc) and the mutated plasmids (− 1994△ − 76AP − 1luc, − 1994△ − 1870AP − 1luc and − 1994△ − 1403CREluc) were constructed from the rat promoter (AF017274), kindly provided by Dr A. Ridall [23] , cloned into the pGL 2 basic vector (Promega) (− 1994 luc).
The reporter CRE-luc was constructed by inserting 4 CRE consensus sites (TGACGTCA) into pLucMCS (Stratagene).
The plasmid harboring the dominant negative form of CREB (ACREB), in which the basic region had been changed into an acidic region [24] , was kindly provided by C. Vinson (National Cancer Institute, Bethesda, USA).
Cell culture, cell transfection
Rat aortic SMCs were prepared from thoracic aortas of Wistar rats and cultured as previously described [25] . Animals were treated in accordance with the Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996). SMCs from passages 5 to 20 were used. Quiescent SMCs were obtained after either a 48-hour or a 24-hour (for gene reporter assay and transduction) incubation period in serum-free DMEM (GIBCO) and were stimulated, depending on the experiment, with PDGF-BB (Sigma) at various concentrations in serum-free medium.
SMCs were transfected in 6-well plates using the SuperFect reagent (Qiagen). Cells were cotransfected with 0.2 μg pGL 2 basic vector (Promega) containing rat OPN promoter fragments and 0.2 μg pHook-LacZ vector (Invitrogen) carrying the β-galactosidase gene. For experiments using plasmids encoding the dominant negative mutant ACREB, cells were co-transfected with 0.14 μg of each plasmid. Empty pcDNA3 vector (Invitrogen) was used as control.
Luciferase and β-galactosidase activities were assayed as previously described [26] . For each sample, luciferase activity was normalized to β-galactosidase activity. Each construct was assayed in triplicate in each experiment and each experiment was performed at least three times.
Adenovirus production and cell transduction
Replication-defective adenovirus vector expressing the dominant negative mutant ACREB (AdACREB) was a gift from C. Vinson (NIH, Bethesda, USA). SMCs grown to semi-confluence were incubated for 48 h at 37°C with either AdACREB or an adenovirus vector expressing LacZ (AdLacZ) at a multiplicity of infection (MOI) of 50 in DMEM containing 5% fetal calf serum (FCS). Cells were then washed with PBS and placed in serum-free medium before stimulation.
RNA extraction and PCR
Total RNA was extracted from cultured SMCs according to the TriReagent manufacturer's instructions (MRC). One μg of total RNA was converted into cDNA using the M-MLV Reverse Transcriptase (Invitrogen). The resulting cDNA was subjected to polymerase chain reaction (PCR) analysis according to the Taq DNA polymerase manufacturer's instructions (Promega). The number of cycles was selected in such a way that the amplification was linear with respect to the amount of RNA input. Each cycle consisted of 30 s denaturation at 94°C, 30 s annealing at 60°C, and 1 min extension at 72°C. The OPN cDNA was amplified using primers 5′-CAGTCGATGTCCCTGACGG-3′ and 5′-GTTG-CTGTCCTGATCAGAGG-3′, the CREB cDNA with primers 5′-AGCACCCACTAGCACCATTG-3′ and 5′-TGACTTGT-GGCAGTAAAGGTC-3' and the control β-actin cDNA with primers 5′-GTTCCGATGCCCGAGGCTCT-3′ and 5′-GCA-TTTGCGTGCACAGATGGA-3′.
siRNA
The OPN siRNA AAGAUGAUAGGUAUCUGAAAU targeting the rat OPN mRNA (Acc NM_012881) and the CREB siRNA AAGCACUUAAGGACCUUUACU targeting the rat CREB mRNA (Acc NM_031017) were designed and synthesized by Eurogentec. Cells were transfected with either 100 nM OPN or CREB siRNA, or universal negative control siRNA (Eurogentec OR-0030-NEG05) using Lipofectamine Plus according to the manufacturer's instructions (Invitrogen) and then placed in serum-free medium for 24 h before stimulation.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assays were performed as previously described [26] using 2 μg of anti-CREB, anti-c-Fos or irrelevant antibody anti-VEGF (Santa Cruz). The OPN promoter fragment containing the −76AP-1 site was PCR amplified using 5′-TGCTTTGGTGTGTTTCCTTC-3′ and 5′-AGGCTTAGCTCCTTCAGTCC-3′ primers, and the −1403CRE site with 5′-ATATTCGATAGTCACAGGTG-3′ and 5′-GCAATTACTTCCTAAGCTTCCATTACCTGAAA-TGGAG-3′ primers.
Western blot analysis
Whole cell extracts and immunoblottings were carried out as described previously [14] . The polyclonal antibody anti-OPN (Sigma) used for OPN detection, was used at a 1/400 dilution. The polyclonal antibodies anti-CREB (Santa Cruz) and anti-phospho CREB (serine 133) (Upstate Technologies) at 1/1000 dilution. α-tubulin detection (Sigma) was used to control equal sample loading.
Migration assay
SMCs migration was performed as previously described [14] using Costar-Transwell inserts. The lower chamber was filled with serum-free DMEM with or without PDGF-BB 50 ng/mL and cells that had migrated beneath the membrane were counted after 6 h, excluding the possibility of proliferation, in 10 microscopic fields (× 20) . Data are expressed as percentage of control, where control is SMC without agonist.
To determine the role of OPN, the blocking monoclonal antibody MPIIIB10 against OPN (DHSB) or control IgG1 (Sigma) were added to the lower chamber at a final concentration of 10 μg/mL, simultaneously with PDGF.
Statistics
Data were analyzed using unpaired, two-tailed Student t-tests. All values are expressed as mean ± S.D. with p ≤ 0.05 considered as the minimum confidence level.
Results
PDGF-induced migration is OPN-dependent
PDGF-BB induced a dose-dependent OPN expression (mRNA and protein) in cultured rat aortic SMCs (Fig. 1A) . The maximal effect was obtained for 50 ng/mL PDGF. At this concentration, PDGF induced a 2.8 fold increase in SMC migration (Fig. 1B) . The role of the autocrine OPN production in PDGF-induced SMC migration was determined by using two different strategies to inhibit either OPN action or OPN expression. In a first method, a blocking antibody anti-OPN was used to neutralize OPN produced by PDGF-stimulated SMCs. When the OPN antibody was added to the lower chamber of the Transwell system, the PDGF-induced migration was reduced by 71% (±14%), while unspecific immunogloblin had no effect (Fig. 1B) . In a second strategy for the inhibition of OPN expression, we used an siRNA selectively targeting OPN mRNA. Untreated cells and control siRNA treated cells retained strong OPN expression in response to PDGF, while OPN expression in OPN siRNA treated cells was decreased by 68.9% (±5.1%) at the mRNA level and 70.7% (±6.1%) at the protein level (Fig. 1C) demonstrating the efficiency of this knock-down strategy. The OPN inactivation in OPN siRNA treated cells decreased PDGF-induced migration by 68.0% (±7.0%) compared to control siRNA treated cells (Fig. 1D ). Altogether these data demonstrated that PDGF-induced SMC migration depends on the autocrine production of OPN induced by PDGF itself in SMCs.
PDGF-induced SMC migration is CREB-dependent
CREB was activated (phosphorylation of Ser133) when SMCs were stimulated by PDGF and this activation was dependent on the PDGF concentration with a maximal effect at 50 ng/mL ( Fig. 2A) . This PDGF concentration was used for Fig. 2 . PDGF-induced CREB activation is MAPK1/2 and PKA-dependent. Quiescent SMCs were incubated in serum-free medium containing 5, 10, 25 or 50 ng/ mL PDGF-BB for 15 min (A) or PDGF-BB 50 ng/mL for the indicated time (B). Phospho-CREB (P-CREB) was detected by western blotting using a polyclonal antibody recognizing phospho-serine 133, and total CREB was detected with a polyclonal antibody. further experiments. CREB phosphorylation was rapidly and transiently induced after PDGF stimulation of cultured SMCs while the level of total CREB remained unchanged (Fig. 2B ).
Many kinases were described to phosphorylate CREB under PDGF stimulation [16] . Pre-treatment of SMCs with specific inhibitors of major intracellular pathways before PDGF stimulation demonstrated that the p38 MAPK pathway, PI3K, calmodulin kinase (CaMK) and protein kinase C (PKC) isoforms were not involved in the PDGFstimulated CREB activation (Fig. 2C) . In contrast, blockades of MAPK kinase (MAPKK) 1/2 and protein kinase A (PKA) inhibited CREB activation by 65% ± 2 and 45% ± 1, respectively (Fig. 2C) . PDGF-induced CREB activation was reduced by 94% when SMCs were treated with a combination of the two inhibitors, indicating that MAPK1/2 and PKA activated CREB by two distinct pathways and were essential to CREB activation by PDGF.
In order to investigate CREB's role in PDGF-induced migration, two different methods were used to inhibit either CREB function or CREB expression in cultured SMCs. In a first method, we used a dominant negative form of CREB (ACREB) which dimerizes with endogenous CREB and prevents its binding to DNA [24] . PDGF-induced CREBmediated transcription was decreased by 81% ± 3 in the presence of ACREB. Proliferative SMCs were transduced with adenoviruses encoding ACREB (AdACREB) or control viruses encoding β-galactosidase (AdLacZ) during 48 h at MOI 50. After 24 h of quiescence, SMC migration was assessed with Transwell system. Following PDGF stimulation, migration of untransduced and AdLacZ transduced SMCs was increased by 3 fold (Fig. 3A) . PDGF-induced SMC migration was inhibited by 77% ± 17 when CREB function was abolished in AdACREB-transduced cells, (Fig. 3A) suggesting that CREB was involved in PDGFstimulated migration. Migration of cultured SMCs was also determined after transfection with either an siRNA targeting the rat CREB mRNA or a control siRNA. Down-regulation of CREB inhibited PDGF-induced migration by 81% ± 7. This effect was specific to CREB since treatment with a control siRNA had no effect on migration (Fig. 3B) . These data therefore demonstrated that PDGF-stimulated SMC migration is largely dependent on CREB activation.
CREB is involved in OPN expression
Previous experiments demonstrated that PDGF-induced SMC migration is dependent not only on autocrine OPN production ( Fig. 1 ) but also on CREB activation (Fig. 3) suggesting that CREB might be implicated in SMC migration by regulating OPN expression. The level of PDGF-mediated OPN expression was evaluated after inhibition of CREB function by either AdACREB or CREB siRNA. SMC transduction by the dominant negative ACREB limited PDGFinduced OPN expression to 34.6% ± 5.0 and 41.0% ± 3.0 at the mRNA and protein levels, respectively (Fig. 4A ). This effect was specific to ACREB expression since control adenovirus AdLacZ had no effect. Moreover, SMC treatment with CREB siRNA inhibited OPN expression at both the mRNA and the protein levels i.e. 55.0% ± 2.6 and 52.2% ± 0.6 respectively (Fig. 4B) confirming the involvement of CREB in OPN expression regulation.
CREB regulates PDGF-induced OPN expression via − 76AP-1 and − 1403CRE sites
CREB is a transcription factor involved in the regulation of many genes. To investigate how CREB could regulate OPN transcription, OPN analysis was conducted with a plasmid harboring the rat OPN promoter driving luciferase gene. SMCs were transfected with the entire promoter construction (− 1994luc), starved and stimulated for 6 h with PDGF-BB 50 ng/mL. In these conditions, OPN promoter transcription was 4.5 fold activated in comparison to unstimulated cells (Fig. 5B) . The involvement of CREB was evaluated by co-transfection of SMCs with a plasmid expressing the dominant negative ACREB. OPN promoter was activated by only 2 fold in cells co-transfected with ACREB plasmid indicating that OPN transcription is under the control of CREB factor (Fig. 5B) . To determine which regions of the OPN promoter were regulated by CREB, various 5′ deletions of this promoter (Fig. 5A) were assayed in combination or not with ACREB plasmid. Regions between − 1599 and − 1014 and between − 294 and + 66 appeared to be implicated in the regulation of OPN expression by PDGF since OPN promoter was less activated when these two regions were deleted (Fig. 5B) . Similarly, ACREB inhibition was decreased only when these two regions were deleted (Fig. 5C ). Together these data showed that CREB regulated OPN expression via these regions.
The three sites of the OPN promoter that could potentially bind CREB factor: − 1870AP-1, − 1403CRE and − 76AP-1 sites were individually mutated. PDGF-induced promoter activation was diminished when − 1403CRE and − 76AP-1 sites were mutated while mutation of − 1870AP-1 site had no effect (Fig. 5D) . Moreover, ACREB inhibition was decreased when − 1403CRE and − 76AP-1 sites were mutated (Fig. 5E) indicating that CREB acts on these two sites. Furthermore the binding of CREB to these two sites of the endogenous OPN promoter was demonstrated using ChIP assays (Fig. 6A) . It could thus be concluded that CREB regulates PDGF-induced OPN expression by acting on − 1403CRE and − 76AP-1 sites of the OPN promoter.
Moreover we have previously demonstrated that c-Fos also binds to the −76AP-1 site of the OPN promoter in UTPstimulated SMC [26] . Since c-Fos was activated by PDGF stimulation of SMC (not shown and [27] ), c-Fos binding to the −76AP-1 site was evaluated by ChIP assay. c-Fos bound to the −76AP-1 site of the endogenous OPN promoter (Fig. 6B) suggesting that c-Fos was associated to CREB and induced OPN transcription.
Discussion
The present study demonstrates that the autocrine expression of OPN plays a key role in PDGF-induced SMC migration. It also shows that the transcription factor CREB, which is activated in PDGF-stimulated SMCs, plays a Fig. 4 . CREB is involved in OPN expression. Proliferating SMCs were transduced with either AdACREB or the control AdLacZ adenovirus (A) or treated with either CREB siRNA or control siRNA (100 nM) (B). After a 24 h incubation in serum-free medium, quiescent treated or untreated SMCs (Untr) were stimulated with PDGF-BB 50 ng/mL for 6 h. OPN expression was analyzed by RT-PCR (left panels) or by western blot using a monoclonal anti-OPN antibody (right panels). Equal loading was verified by β-actin amplification, for RNAs, and by α-tubulin detection, for proteins. Quantification of the signal density was done by image analysis (Scion Image). Histograms present the ratio of OPN/β-actin signal. The ratio obtained for untreated cells was taken as reference (=1). ⁎ p b 0.01 vs Untr PDGF, n =3. significant role in PDGF-induced SMC migration, probably by regulating OPN expression.
Many studies have previously demonstrated that PDGF-BB is able to induce SMC migration [2] , but only few mechanisms have been proposed to explain this effect. However, pharmacological inhibition experiments have demonstrated the involvement in this process of key intracellular actors, such as MAPK1/2 and p38 MAPK, PI3K and Rho-RhoK [16, 17, 28] . Other studies have shown that PDGF-BB also acts via the activation of integrin pathway since integrin blockade inhibits the PDGF-induced SMC migration [8] [9] [10] . Moreover, it has been described that PDGF acts synergistically with extracellular matrix proteins (laminin, fibronectin, collagens) to promote SMC migration [29] . Another matrix protein, OPN, which can induce SMC migration by itself [30] , seems particularly implicated. Indeed, exogenously added OPN has been reported to enhance PDGF activation of major events involved in SMC migration, i.e. activation of the focal adhesion kinase [31] and of the expression of MMP [15] . Since OPN is produced by SMCs when they are stimulated by various chemotactic factors [14, 32] , particularly by PDGF [11] , it could be hypothesized that PDGF-induced OPN is involved in the migratory process induced by this factor. Our study clearly shows that PDGF stimulation of SMCs leads to the expression of OPN, confirming previous results [11] and demonstrates for the first time that extracellular OPN autocrinally produced by SMCs plays a major role in the activation of the migration process induced by the reference SMC chemotactic factor PDGF. In a previous work, we demonstrated that extracellular nucleotide-mediated migration is also dependent on OPN expression [14] . A more general concept can thus be proposed, in which autocrinally OPN production is necessary to SMC migration induced, at least, by chemotactic factors acting through tyrosine kinase or G protein-coupled receptors. Several transcription factors are induced in PDGFactivated SMCs: Ets-1 [33] , CREB, AP-1, SRE, NF-kB and NFAT [18] . However, only some of them, such as the AP-1 component c-Jun [34] , have been involved in PDGFinduced SMC migration. The activation of CREB by PDGF, but also by other SMC chemotactic factors (TNFα, angiotensin II, thrombin, nucleotides), has been well documented [19] [20] [21] [22] and suggests that this transcription factor could be involved in SMC migration [21] . Our study demonstrates that CREB plays a critical role in PDGFinduced SMC migration since CREB inhibition reduces SMC migration by about 80%. Our work suggests that this strong effect of CREB is mainly due to its role in OPN activation since CREB inhibition decreases OPN expression by 60%, but also that CREB can modulate OPN-independent SMC migration probably by regulating expression of CREBdependent genes involved in the migration process, such as c-Fos, Egr-1 or MMPs [35] .
Mechanisms involved in the regulation of OPN gene transcription by PDGF are poorly understood. Previously, several cis-regulatory elements and transcription factors have been shown to be involved in OPN transcription depending on the cell type or the cell activator [36] [37] [38] , underlining the complexity and the specificity of the OPN gene regulation. Here, we demonstrate for the first time that the transcription factor CREB participates in the activation of OPN transcription induced by PDGF in SMCs. The CREB transcription factor was known to generally bind CRE sites. However, some reports suggest that CREB can occasionally bind AP-1 sites [39] [40] [41] . Here, we describe an original mechanism in which CREB binds to both a hitherto undescribed CRE site located at − 1403, and an AP-1 site located at − 76 on the OPN promoter. Moreover, we show that PDGF also induces c-Fos binding to − 76AP-1 site.
Since CREB and c-Fos bind this AP-1 site in PDGFstimulated SMCs, it could be hypothesized that CREB forms a complex with AP-1 proteins on this site [40] [41] [42] . We have previously shown that UTP-mediated OPN expression involved c-Fos binding to the − 76AP-1 site and NF-kB binding to the − 1800NF-κB site [43] . The present study demonstrates that PDGF-induced OPN expression also involves the − 76AP-1 site. In contrast, PDGF-induced OPN expression does not involve the − 1800NF-κB site (data not shown). These findings demonstrate that OPN expression triggered by these two chemotactic factors, UTP and PDGF, depends on both common and specific mechanisms.
Migration and proliferation of vascular SMCs are two events involved in atherosclerosis, restenosis after balloon angioplasty, and stenosis of grafted vessels. PDGF found in stenotic vessels is recognized as a major factor involved in intimal thickening formation, particularly via the induction of media SMC migration. Moreover, several reports show that OPN is overexpressed in experimental and human intimal thickenings, and is also involved in development of intimal hyperplasia [32, 44, 45] . Our study, demonstrating that PDGF acts in a large part via the autocrine production of OPN, establishes that the effects of these factors are closely connected. So, the simultaneous blockade of PDGF or its receptors [3, 4] and of OPN expression or of its integrin receptors [15, 46] could be a promising therapeutic strategy to limit the development of restenotic lesions or atheromatous plaques.
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